The European Cancer Congress 2015

login
My congress planner
close
Forgot password

Create account

Searchable Programme for ECC2015

Keyword / Author:
  • 26
    SAT
    07:45 – 08:30
    Sarcoma: Soft Tissue

    Teaching Lecture: Is There Any New Treatment in Metastatic STS?

    Chair: I. Judson (United Kingdom)

    Speaker: J.Y. Blay (France)

  • 26
    SAT
    10:30 – 12:40
    Abstract nr
    Sarcoma: Soft Tissue

    Proffered Paper Session: Sarcoma: Soft Tissue and Bone

    Chair: J.Y. Blay (France)

    Chair: S. Bonvalot (France)

    10:30
    3400
    Management of Desmoid Tumours (DT): A nationwide survey after labeling of 2 expert networks (RRePS and NetSarc)
    Speaker: N. Penel (France)
    Display abstract

    10:45
    3401
    Absence of progression, not extent of remission defines prognosis in soft tissue sarcoma – an analysis of the EORTC 62012 study
    Speaker: V. Grünwald (Germany)
    Display abstract

    11:00
    3402
    Time interval (TI) between surgery and start of adjuvant radiotherapy (RT): A retrospective analysis of 1150 cases from the French Sarcoma Group
    Speaker: J. Fourquet (France)
    Display abstract

    11:15
    Discussant : R. Haas (Netherlands)

    11:25
    3403
    Final overall survival (OS) analysis of the randomized phase 3 study of trabectedin (T) or dacarbazine (D) for the treatment of patients (pts) with advanced leiomyosarcoma (LMS) or liposarcoma (LPS)
    Speaker: S. Patel (USA)
    Display abstract

    11:40
    3404
    External validation of a nomogram predicting disease-free (DFS) and overall survival (OS) in patients (pts) with primary retroperitoneal sarcoma (pRPS)
    Speaker: C. Raut (USA)
    Display abstract

    11:55
    3405
    The role of pharmacogenetics in osteosarcoma
    Speaker: M. Hagleitner (Netherlands)
    Display abstract

    12:10
    Discussant : S. Sandrucci (Italy)

    12:20
    13LBA
    LATE BREAKING ABSTRACT: Improved overall survival by adding regional hyperthermia to neo-adjuvant chemotherapy in patients with localized high-risk soft tissue sarcoma (HR-STS): Long-term outcomes of the EORTC 62961/ESHO randomized phase III study
    Speaker: R.D. Issels (Germany)
    Display abstract

    12:30
    Discussant : J.Y. Blay (France)

  • 26
    SAT
    15:15 – 16:15
    Sarcoma: Soft Tissue

    Special Session: Successes and Uncertainties for Targeted Therapies of Sarcomas

    Chair: J.Y. Blay (France)

    15:15
    Trabectedin and M2 macrophages
    Speaker: M. D’Incalci (Italy)
    Display Presentation Details

    15:25
    MDM2/CDK4: Good targets?
    Speaker: O. Mir (France)

    15:35
    CSF1R Ab or Ib
    Speaker: G. Demetri (USA)

    Discussion

  • 27
    SUN
    08:00 – 08:45
    Sarcoma: Soft Tissue

    Teaching Lecture: Long Term Physical Outcomes of Bone Sarcoma Surgery in Children and Young Adults

    Chair: R. Ladenstein (Austria)

    Speaker: R.J. Grimer (United Kingdom)
    Display Presentation Details

  • 27
    SUN
    09:00 – 10:30
    Sarcoma: Soft Tissue

    Scientific Symposium: Local Treatment Is the Key Medical Scientific Question

    Chair: S. Bonvalot (France)

    Co-Chair: P. Rutkowski (Poland)
    Display Presentation Details

    09:00
    Quality assurance in surgery
    Speaker: A. Gronchi (Italy)
    Display Presentation Details

    09:20
    Hallmarks of hyperthermia
    Speaker: R.D. Issels (Germany)
    Display Presentation Details

    09:40
    Nanoparticle therapies
    Speaker: S. Bonvalot (France)
    Display Presentation Details

    10:00
    New questions for RT in randomised trials
    Speaker: R. Haas (Netherlands)
    Display Presentation Details

    Discussion & Roundup

Print all results list